120 related articles for article (PubMed ID: 33612089)
1. Label-Free Quantitative Comparison of Cervical Mucus Peptides in Subjects With Endocervical Adenocarcinoma and Adenocarcinoma in Situ.
Shi F; Li X; Ma Z; Luan T; Zhong T; Gu Y
Technol Cancer Res Treat; 2021; 20():1533033821997825. PubMed ID: 33612089
[TBL] [Abstract][Full Text] [Related]
2. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
3. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of human cervical adenocarcinoma mucus to identify potential protein biomarkers.
Ma Z; Chen J; Luan T; Chu C; Wu W; Zhu Y; Gu Y
PeerJ; 2020; 8():e9527. PubMed ID: 33194326
[TBL] [Abstract][Full Text] [Related]
5. Tissue-based Immunohistochemical Biomarker Expression in Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review.
Lee S; Sahasrabuddhe VV; Mendoza-Cervantes D; Zhao R; Duggan MA
Int J Gynecol Pathol; 2018 Mar; 37(2):128-140. PubMed ID: 28582347
[TBL] [Abstract][Full Text] [Related]
6. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
[TBL] [Abstract][Full Text] [Related]
7. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
8. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
9. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
[TBL] [Abstract][Full Text] [Related]
10. SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma.
Hopman ANH; Moshi JM; Hoogduin KJ; Ummelen M; Henfling MER; van Engeland M; Wouters KAD; Stoop H; Looijenga LHJ; Ramaekers FCS
Histopathology; 2020 Feb; 76(3):383-393. PubMed ID: 31444787
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.
Asaka S; Nakajima T; Kugo K; Kashiwagi R; Yazaki N; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2020 Apr; 476(4):499-510. PubMed ID: 31932920
[TBL] [Abstract][Full Text] [Related]
12. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
Jaworski RC
Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
[TBL] [Abstract][Full Text] [Related]
13. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist?
Goldstein NS; Ahmad E; Hussain M; Hankin RC; Perez-Reyes N
Am J Clin Pathol; 1998 Aug; 110(2):200-9. PubMed ID: 9704619
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of cytologic predictions of endocervical glandular abnormalities: histologic outcomes in 123 cases.
Roberts JM; Thurloe JK; Biro C; Hyne SG; Williams KE; Bowditch RC
J Low Genit Tract Dis; 2005 Apr; 9(2):71-7. PubMed ID: 15870526
[TBL] [Abstract][Full Text] [Related]
15. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
[TBL] [Abstract][Full Text] [Related]
16. Superficially Spreading Endocervical Adenocarcinoma
Hwang I; Lee J; Choi KH; Han J; Kim HS
Case Rep Oncol; 2020; 13(3):1530-1536. PubMed ID: 33564294
[TBL] [Abstract][Full Text] [Related]
17. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray.
Zhang ZQ; Li XJ; Liu GT; Xia Y; Zhang XY; Wen H
World J Gastroenterol; 2013 Nov; 19(43):7795-803. PubMed ID: 24282368
[TBL] [Abstract][Full Text] [Related]
18. Cytological Diagnoses of Adenocarcinoma in situ of the Cervix: Common Misdiagnoses.
Li S; Tian D; Li Y
Acta Cytol; 2015; 59(1):91-96. PubMed ID: 25766846
[TBL] [Abstract][Full Text] [Related]
19. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
[TBL] [Abstract][Full Text] [Related]
20. HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation.
Talia KL; Stewart CJR; Howitt BE; Nucci MR; McCluggage WG
Am J Surg Pathol; 2017 Aug; 41(8):1023-1033. PubMed ID: 28394803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
